Performance Anomaly Detection in Athletics: A Benchmarking System with Visual Analytics

ArXi:2604.21953v1 Announce Type: new Anti-doping programs rely on biological testing to detect performance-enhancing drugs, but such testing costs over $800 per sample and is limited by short detection windows for many prohibited substances. These constraints leave large portions of athletes without regular testing, motivating complementary screening approaches that analyze routine competition results to identify suspicious performance patterns.